Skip to main content
$72.06 $1.70 (2.4%)

04:00 PM EDT on 09/28/22

Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 5 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Current Price $72.06 Mkt Cap $150.2B
Open $71.07 P/E Ratio 25.34
Prev. Close $72.06 Div. (Yield) $2.16 (3.1%)
Daily Range $71.02 - $72.08 Volume 12,412,730
52-Wk Range $53.22 - $80.59 Avg. Daily Vol. 9,698,265

Caps

How do you think NYSE:BMY will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,833 Outperform
114 Underperform
 

All-Star Players

335 Outperform
16 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:BMY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Craigs22 (47.36)
Submitted October 04, 2021

Extremely attractive valuation for a company with a strong existing set of drugs and upside in their pipeline

msabol01 (86.33)
Submitted April 02, 2017

Strong pipeline and a culture that wants to innovate. Strong focus on patients. Leadership seems to struggle with launching products and being competitive out the door. Long term will either find BMY on strong footing or acquired.

Recent Community Commentary

Read the most recent pitches from players about BMY.

Recs

1
Member Avatar Craigs22 (47.36) Submitted: 10/4/2021 12:15:19 AM : Outperform Start Price: $58.56 NYSE:BMY Score: +37.49

Extremely attractive valuation for a company with a strong existing set of drugs and upside in their pipeline

Recs

1
Member Avatar asdfk123 (68.80) Submitted: 9/30/2021 12:32:58 PM : Outperform Start Price: $41.40 NYSE:BMY Score: +50.93

Added to position @$59.72 per share.

Recs

0
Member Avatar TMFkodyk123 (70.60) Submitted: 9/7/2021 7:32:03 PM : Outperform Start Price: $63.18 NYSE:BMY Score: +31.89

BMY's growth prospects are promising with anticoagulant blockbuster Eliquis and oncology blockbusters Revlimid and Opdivo. When combined with BMY's valuation, BMY is poised to beat the S&P 500 over the next 5-10 years.

Leaderboard

Find the members with the highest scoring picks in BMY.

Score Leader

99FE905

99FE905 (< 20) Score: +315.07

The Score Leader is the player with the highest score across all their picks in BMY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
99FE905 < 20 6/20/2008 Outperform 5Y $11.94 +503.62% +188.55% +315.07 0 Comment
tkaskmaster 48.80 6/23/2008 Outperform 3M $11.95 +503.00% +189.44% +313.56 0 Comment
tylerfu 62.60 6/13/2008 Outperform 5Y $12.04 +498.43% +185.67% +312.76 0 Comment
SandmanKy 77.03 6/13/2008 4/28/2020 Outperform 5Y $12.04 +498.43% +185.67% +312.76 1 Comment
Nacho2k 78.21 6/13/2008 Outperform 3Y $12.11 +495.14% +182.75% +312.40 0 Comment
CLF65 92.31 6/24/2008 9/8/2009 Outperform 1Y $11.94 +503.62% +191.46% +312.16 0 Comment
tnovosad < 20 6/13/2008 Outperform NS $12.12 +494.56% +182.48% +312.08 0 Comment
cyberDEAD < 20 6/20/2008 Outperform 1Y $12.02 +499.37% +187.51% +311.85 0 Comment
snowape 83.91 6/18/2008 Outperform 3Y $12.04 +498.59% +186.79% +311.79 1 Comment
bigbird0459 < 20 6/11/2008 Outperform NS $12.10 +495.43% +184.46% +310.97 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BMY.